Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2024)Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.
Sectors & IndustriesHealthcare
Sector: Healthcare
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | $11.49B | $3.70B | $919.43M | $597.60M | $2.67 | 8.87% | 14.45% | 74.51% | 38.71% | 2024-04-30 | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.64B | $582.02M | $221.51M | $128.85M | $2.17 | 32.93% | N/A | -29.32% | N/A | 2024-05-29 | |
| SMLR | SEMLER SCIENTIFIC INC | $182.18M | $68.18M | $24.70M | $20.58M | $3.06 | 20.28% | 25.98% | 43.66% | 30.13% | 2024-05-08 | |
| VYGR | VOYAGER THERAPEUTICS INC | $402.91M | $250.01M | $126.46M | $132.33M | $3.08 | 511.16% | 101.01% | N/A | N/A | 2024-05-07 | |
| INMD | INMODE LTD | $1.43B | $492.05M | $217.89M | $197.92M | $2.37 | 8.32% | 37.49% | 20.92% | 42.03% | 2024-05-02 | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $13.71B | $1.89B | $358.00M | $249.70M | $2.56 | 26.76% | 33.13% | 59.01% | 61.92% | 2024-05-01 | |
| PGNY | PROGYNY INC | $3.14B | $1.09B | $69.67M | $62.04M | $0.65 | 38.34% | 59.52% | 96.97% | 74.65% | 2024-05-23 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | $120.65M | $380.79M | $55.39M | $49.27M | $0.73 | 1,612.94% | N/A | N/A | N/A | 2024-06-06 | |
| SDGR | SCHRODINGER INC | $1.69B | $216.67M | $56.24M | $40.72M | $0.57 | 19.73% | 26.59% | N/A | N/A | 2024-06-18 | |
| CNC | CENTENE CORP | $40.48B | $154.00B | $5.62B | $2.70B | $4.97 | 6.54% | 20.70% | 137.80% | 16.56% | 2024-04-26 | |
| UTHR | UNITED THERAPEUTICS CORP | $11.10B | $2.33B | $1.39B | $984.80M | $21.04 | 20.20% | 7.41% | 31.66% | 9.22% | 2024-05-01 | |
| CCRN | CROSS COUNTRY HEALTHCARE INC | $604.23M | $2.02B | $130.45M | $72.63M | $2.07 | -28.04% | 19.86% | -59.33% | N/A | 2024-05-01 | |
| GILD | GILEAD SCIENCES INC | $81.31B | $27.12B | $10.55B | $5.67B | $4.54 | -0.60% | 4.15% | 24.04% | 1.57% | ||
| CORT | CORCEPT THERAPEUTICS INC | $2.30B | $482.38M | $109.00M | $105.50M | $1.02 | 20.04% | 13.93% | 7.37% | 9.43% | 2024-05-01 | |
| EXEL | EXELIXIS INC | $7.13B | $1.83B | $312.21M | $207.77M | $0.65 | 13.60% | 16.47% | 14.04% | -22.47% | 2024-04-30 | |
| JNJ | JOHNSON & JOHNSON | $353.66B | $85.16B | $45.15B | $35.15B | $13.88 | 6.46% | 0.86% | 103.22% | 19.48% | ||
| OSUR | ORASURE TECHNOLOGIES INC | $388.17M | $405.47M | $77.19M | $53.66M | $0.73 | 4.64% | 17.41% | N/A | 17.21% | 2024-05-08 | |
| VMD | VIEMED HEALTHCARE INC | $310.44M | $183.01M | $36.68M | $10.24M | $0.27 | 31.82% | 23.21% | 68.75% | 1.55% | 2024-06-06 | |
| SIGA | SIGA TECHNOLOGIES INC | $614.23M | $139.92M | $88.31M | $68.07M | $0.95 | 26.31% | -21.75% | 106.52% | -29.04% | 2024-05-02 | |
| PCRX | PACIRA BIOSCIENCES INC | $1.19B | $674.98M | $157.58M | $41.96M | $0.91 | 1.22% | 14.88% | 160.00% | N/A | 2024-05-01 | |
| KMDA | KAMADA LTD | $298.89M | $142.52M | $22.44M | $8.28M | $0.17 | 10.19% | 4.48% | N/A | -20.93% | 2024-05-22 | |
| PBYI | PUMA BIOTECHNOLOGY INC | $235.25M | $235.64M | $47.52M | $21.59M | $0.46 | 3.34% | -1.25% | N/A | N/A | 2024-05-02 | |
| AMPH | AMPHASTAR PHARMACEUTICALS INC | $1.96B | $644.40M | $225.48M | $137.55M | $2.85 | 29.14% | 16.94% | 51.60% | N/A | 2024-05-07 | |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $336.78M | $274.42M | $22.31M | $28.52M | $1.24 | 11.20% | 13.81% | N/A | 28.06% | 2024-05-06 | |
| ADUS | ADDUS HOMECARE CORP | $1.49B | $1.06B | $106.56M | $62.52M | $3.91 | 11.31% | 15.43% | 34.83% | 23.52% | 2024-05-07 | |
| HALO | HALOZYME THERAPEUTICS INC | $4.88B | $829.25M | $451.95M | $281.59M | $2.13 | 25.62% | 40.43% | 43.92% | N/A | 2024-05-07 | |
| HCM | HUTCHMED (CHINA) LTD | $3.31B | $838.00M | N/A | $100.78M | $0.60 | 96.52% | 31.38% | N/A | N/A | ||
| DOCS | DOXIMITY INC | $4.40B | $468.33M | $186.53M | $137.63M | $0.72 | 16.58% | N/A | 14.29% | N/A | 2024-05-16 | |
| RPRX | ROYALTY PHARMA PLC | $16.79B | $2.35B | $1.32B | $1.13B | $2.54 | 5.24% | 5.58% | 2,440.00% | N/A | 2024-05-09 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $15.50B | $2.42B | $310.28M | $167.65M | $0.89 | 15.42% | 10.16% | 17.11% | N/A | ||
| EW | EDWARDS LIFESCIENCES CORP | $52.89B | $6.00B | $1.79B | $1.40B | $2.31 | 11.56% | 10.03% | -6.10% | 14.97% | ||
| CHE | CHEMED CORP | $8.67B | $2.26B | $414.34M | $272.51M | $18.11 | 6.06% | 4.90% | 8.31% | 7.19% | ||
| MCK | MCKESSON CORP | $70.95B | $301.51B | $4.53B | $3.00B | $22.24 | 10.08% | 7.15% | 1.23% | N/A | 2024-05-07 | |
| MDT | MEDTRONIC PLC | $105.23B | $32.32B | $8.88B | $4.20B | $3.15 | 5.03% | 1.13% | 3.28% | -2.90% | 2024-05-23 | |
| ASTH | ASTRANA HEALTH INC | $2.03B | $1.39B | $133.74M | $60.72M | $1.30 | 21.19% | 21.68% | 30.00% | 31.55% | 2024-05-06 | |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $1.15B | $566.77M | $308.33M | $48.16M | $1.43 | 22.17% | 15.11% | N/A | N/A | 2024-05-02 | |
| TGTX | TG THERAPEUTICS INC | $2.15B | $233.66M | $25.89M | $12.67M | $0.09 | 8,290.02% | 333.86% | N/A | N/A | 2024-04-29 | |
| NSYS | NORTECH SYSTEMS INC | $47.41M | $139.33M | $8.00M | $6.87M | $2.53 | 3.88% | 4.21% | 237.33% | 111.35% | 2024-05-08 | |
| STAA | STAAR SURGICAL CO | $2.29B | $322.42M | $31.83M | $21.35M | $0.44 | 13.37% | 21.07% | -46.99% | 29.67% | 2024-05-01 | |
| ROIV | ROIVANT SCIENCES LTD | $8.77B | $123.24M | $4.58B | $4.47B | $5.56 | 185.76% | N/A | N/A | N/A | 2024-06-26 | |
| LNTH | LANTHEUS HOLDINGS INC | $4.47B | $1.30B | $491.01M | $326.66M | $4.79 | 38.65% | 30.44% | 1,068.29% | 35.21% | 2024-05-02 | |
| CVS | CVS HEALTH CORP | $84.73B | $357.78B | $13.81B | $8.34B | $6.49 | 10.95% | 12.95% | 97.26% | N/A | 2024-05-01 | |
| DCGO | DOCGO INC | $363.56M | $624.29M | $27.85M | $6.86M | $0.07 | 41.72% | N/A | -79.41% | N/A | 2024-05-08 | |
| GMAB | GENMAB A | $18.14B | $2.40B | N/A | $633.48M | $0.97 | 16.77% | 39.38% | -17.74% | 21.77% | 2024-05-02 | |
| UTMD | UTAH MEDICAL PRODUCTS INC | $237.92M | $50.22M | $26.46M | $16.64M | $4.58 | -3.93% | 3.64% | 1.10% | -1.62% | ||
| MOH | MOLINA HEALTHCARE INC | $20.64B | $35.85B | $1.72B | $1.07B | $18.55 | 10.82% | 14.32% | 24.92% | 7.45% | ||
| SLP | SIMULATIONS PLUS INC | $912.31M | $64.67M | $16.85M | $10.52M | $0.53 | 18.86% | 15.66% | 1.92% | 4.27% | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | $3.52B | $6.66B | $733.50M | $243.49M | $1.91 | 5.22% | 5.57% | 55.28% | 13.37% | 2024-05-03 | |
| AZN | ASTRAZENECA PLC | $232.62B | $47.61B | $14.25B | $6.33B | $2.05 | 8.60% | 16.27% | 34.98% | 16.57% | ||
| VEEV | VEEVA SYSTEMS INC | $32.12B | $2.36B | $632.34M | $525.71M | $3.27 | 9.68% | 22.35% | 4.14% | 15.51% | 2024-05-29 | |
| COR | CENCORA INC | $47.83B | $271.58B | $3.01B | $1.87B | $9.28 | 12.31% | 9.46% | 11.14% | 10.95% | 2024-05-01 | |
| MEIP | MEI PHARMA INC | $20.65M | $72.65M | $21.69M | $19.84M | $2.97 | 16.10% | 83.24% | N/A | N/A | 2024-05-09 | |
| ICLR | ICON PLC | $24.81B | $8.23B | $1.62B | $683.12M | $8.30 | 5.29% | 25.44% | 32.80% | 6.18% | ||
| SNY | SANOFI | $124.86B | $49.94B | $14.09B | $5.81B | $2.32 | 6.87% | 4.70% | -32.73% | 3.84% | ||
| DXCM | DEXCOM INC | $54.88B | $3.80B | $991.00M | $639.30M | $1.65 | 25.78% | 27.51% | 117.11% | N/A | ||
| CAH | CARDINAL HEALTH INC | $25.25B | $216.15B | $1.89B | $639.00M | $2.57 | 11.99% | 8.78% | N/A | N/A | 2024-05-02 | |
| MDXG | MIMEDX GROUP INC | $917.76M | $321.48M | $32.57M | $58.23M | $0.40 | 20.03% | -2.19% | N/A | N/A | 2024-04-30 | |
| PRVA | PRIVIA HEALTH GROUP INC | $2.13B | $1.66B | $29.23M | $23.08M | $0.20 | 22.19% | 20.31% | N/A | N/A | 2024-05-22 | |
| ALC | ALCON INC | $38.89B | $9.46B | $2.25B | $974.00M | $1.98 | 8.47% | 5.74% | 191.18% | N/A | 2024-05-14 | |
| PODD | INSULET CORP | $11.48B | $1.70B | $323.60M | $206.30M | $2.96 | 30.02% | 24.66% | 4,128.57% | 118.09% | 2024-05-09 | |
| LMAT | LEMAITRE VASCULAR INC | $1.41B | $193.48M | $48.99M | $30.11M | $1.36 | 19.69% | 12.88% | 44.68% | 2.88% | 2024-05-02 | |
| AMN | AMN HEALTHCARE SERVICES INC | $2.13B | $3.79B | $500.98M | $210.68M | $5.38 | -27.73% | 12.15% | -45.98% | 12.47% | 2024-05-09 | |
| TALK | TALKSPACE INC | $520.22M | $150.05M | -$22.01M | -$19.18M | -$0.12 | 25.49% | N/A | N/A | N/A | 2024-05-07 | |
| ISRG | INTUITIVE SURGICAL INC | $132.35B | $7.32B | $2.53B | $1.99B | $5.64 | 13.81% | 13.71% | 52.02% | 11.00% | ||
| IRMD | IRADIMED CORP | $525.13M | $65.56M | $22.50M | $17.19M | $1.36 | 23.00% | 16.59% | 33.33% | 18.18% | 2024-05-02 | |
| THC | TENET HEALTHCARE CORP | $9.75B | $20.56B | $2.69B | $611.00M | $6.01 | 6.18% | 2.35% | 56.51% | 42.58% | 2024-04-30 | |
| ZBH | ZIMMER BIOMET HOLDINGS INC | $24.56B | $7.39B | $2.22B | $1.02B | $4.91 | 6.55% | -1.40% | 346.36% | N/A | 2024-05-02 | |
| GSK | GSK PLC | $82.97B | $38.39B | $8.20B | $6.24B | $3.08 | 8.66% | -0.37% | -65.61% | 5.64% | 2024-05-01 | |
| GMED | GLOBUS MEDICAL INC | $6.82B | $1.57B | $290.00M | $122.87M | $1.09 | 53.34% | 17.08% | -42.33% | -7.39% | 2024-05-07 | |
| HOLX | HOLOGIC INC | $17.77B | $3.97B | $1.06B | $515.10M | $2.12 | -11.12% | 4.03% | -46.46% | N/A | 2024-05-02 | |
| WST | WEST PHARMACEUTICAL SERVICES INC | $26.82B | $2.93B | $833.50M | $568.70M | $7.67 | 1.56% | 10.91% | 3.51% | 20.98% | ||
| ABT | ABBOTT LABORATORIES | $185.42B | $40.11B | $10.54B | $5.72B | $3.28 | -8.12% | 5.58% | -16.75% | 19.61% | ||
| HUM | HUMANA INC | $37.53B | $109.24B | $4.20B | $1.99B | $16.29 | 14.22% | 13.21% | -34.29% | 4.84% | ||
| UNH | UNITEDHEALTH GROUP INC | $455.31B | $371.62B | $35.57B | $22.38B | $24.12 | 14.64% | 10.43% | 12.34% | 14.14% | ||
| BRKR | BRUKER CORP | $11.09B | $2.96B | $659.80M | $427.20M | $2.92 | 17.14% | 9.36% | 46.00% | 20.49% | 2024-05-02 | |
| FONR | FONAR CORP | $113.14M | $102.42M | $25.75M | $12.16M | $1.89 | 5.78% | 4.06% | 51.20% | -8.83% | 2024-05-13 | |
| BIIB | BIOGEN INC | $29.48B | $9.66B | $1.85B | $1.17B | $8.05 | -4.37% | -6.89% | -62.80% | -19.14% | ||
| CI | CIGNA GROUP | $103.64B | $195.27B | $9.79B | $5.16B | $17.57 | 8.17% | 32.04% | -18.88% | 10.45% | 2024-05-02 | |
| PEN | PENUMBRA INC | $7.95B | $1.06B | $106.91M | $90.95M | $2.37 | 24.95% | 18.93% | N/A | 65.65% | 2024-05-07 | |
| NVS | NOVARTIS AG | $202.12B | $49.92B | N/A | $15.25B | $7.41 | 8.81% | 1.48% | 125.91% | 6.77% | ||
| BNTX | BIONTECH SE | $20.61B | $4.15B | $1.51B | $1.01B | $4.21 | -76.96% | 96.02% | -89.58% | N/A | 2024-05-17 | |
| ATR | APTARGROUP INC | $9.25B | $3.49B | $664.15M | $284.49M | $4.34 | 4.97% | 4.75% | 18.58% | 6.82% | 2024-04-26 | |
| KIDS | ORTHOPEDIATRICS CORP | $705.07M | $148.73M | -$4.13M | -$20.97M | -$0.92 | 21.62% | 20.91% | N/A | N/A | 2024-05-07 | |
| STE | STERIS PLC | $19.91B | $5.41B | $1.39B | $566.84M | $5.71 | 13.04% | 14.65% | N/A | 12.35% | 2024-05-08 | |
| STRR | STAR EQUITY HOLDINGS INC | $13.91M | $45.79M | $26.87M | $23.22M | $1.61 | -19.88% | -15.16% | N/A | 34.19% | 2024-06-20 | |
| HSIC | HENRY SCHEIN INC | $9.36B | $12.34B | $871.00M | $416.00M | $3.18 | -2.44% | 5.55% | -19.49% | -1.96% | 2024-05-07 | |
| REGN | REGENERON PHARMACEUTICALS INC | $97.76B | $13.12B | $4.69B | $3.95B | $37.05 | 7.76% | 20.58% | -8.54% | 10.34% | 2024-05-02 | |
| ZTS | ZOETIS INC | $70.22B | $8.54B | $3.67B | $2.34B | $5.08 | 5.74% | 7.96% | 12.64% | 11.41% | 2024-05-02 | |
| TFX | TELEFLEX INC | $9.73B | $2.97B | $759.97M | $356.33M | $7.58 | 6.57% | 3.97% | -2.07% | 11.54% | 2024-05-02 | |
| BTMD | BIOTE CORP | $415.89M | $185.36M | $15.85M | $3.32M | $0.13 | 12.37% | N/A | N/A | N/A | 2024-05-07 | |
| VNDA | VANDA PHARMACEUTICALS INC | $257.77M | $192.64M | $9.35M | $2.51M | $0.04 | -24.27% | -0.05% | -63.64% | -39.66% | 2024-05-01 | |
| RVTY | REVVITY INC | $12.61B | $2.75B | $1.25B | $693.09M | $5.56 | -16.95% | -0.20% | 23.28% | 20.93% | 2024-04-29 | |
| PLX | PROTALIX BIOTHERAPEUTICS INC | $86.20M | $65.49M | $11.65M | $8.31M | $0.12 | 37.48% | 13.85% | N/A | N/A | 2024-05-02 | |
| OPCH | OPTION CARE HEALTH INC | $5.09B | $4.43B | $495.02M | $272.67M | $1.53 | 9.59% | 21.82% | 73.86% | N/A | 2024-05-15 | |
| PINC | PREMIER INC | $2.49B | $1.32B | $368.68M | $167.33M | $1.40 | -3.37% | 6.01% | -5.41% | N/A | 2024-05-07 | |
| DBVT | DBV TECHNOLOGIES SA | $132.88M | $15.73M | -$86.72M | -$72.73M | -$0.38 | 224.69% | -0.69% | N/A | N/A | 2024-05-02 | |
| DVA | DAVITA INC | $11.64B | $12.14B | $2.06B | $691.54M | $7.62 | 4.57% | 1.26% | 26.37% | 52.30% | 2024-05-02 | |
| QTRX | QUANTERIX CORP | $593.41M | $122.37M | -$39.08M | -$32.33M | -$0.86 | 15.96% | 26.60% | N/A | N/A | 2024-06-03 | |
| A | AGILENT TECHNOLOGIES INC | $39.96B | $6.74B | $1.69B | $1.24B | $4.22 | -2.81% | 6.19% | -5.17% | 3.46% | 2024-05-21 | |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL INC | $11.70B | $4.13B | $1.03B | $474.62M | $9.27 | 3.86% | 12.75% | -3.13% | 14.45% | 2024-05-09 |
Healthcare Industries
| Industry | Stocks | 1d % | 1w % | 1m % | 1y % | Zen Score | P/E ratio | P/B Ratio | ROE | ROA | ROCE | Upside/Downside | Consensus |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 683 | -1.43% | -0.98% | -10.29% | -23.66% | 15.41x | 5.80x | -70.12% | +3.09% | +21.67% | +94.43% | Strong Buy | ||
| 66 | -1.46% | +3.15% | -6.10% | -2.37% | 38.32x | 4.15x | -21.99% | +6.51% | +11.16% | +11.37% | Buy | ||
| 17 | -0.44% | +1.03% | -4.38% | +10.77% | 158.47x | 6.14x | +32.64% | +7.65% | +14.34% | +16.38% | Buy | ||
| 90 | -0.21% | +1.19% | -3.82% | -8.54% | 33.56x | 2.07x | +11.35% | +2.70% | +5.03% | +39.21% | Strong Buy | ||
| 12 | -0.26% | -0.00% | -2.97% | +3.20% | 18.89x | 2.93x | +20.00% | +6.14% | +14.19% | +15.46% | Buy | ||
| 61 | -1.49% | -0.23% | -8.85% | -25.56% | 72.09x | 3.36x | +6.61% | +2.35% | +5.94% | +39.80% | Buy | ||
| 50 | -2.52% | +1.68% | -6.03% | +3.16% | -0.78x | 4.54x | -88.99% | +6.21% | +13.14% | +18.46% | Buy | ||
| 154 | -1.51% | -0.01% | -3.44% | -16.25% | 29.73x | 3.71x | +10.90% | +5.40% | +7.83% | +23.04% | Buy | ||
| 9 | +0.54% | +2.42% | -0.67% | +34.81% | 26.23x | 147.35x | +18.21% | +3.52% | +19.63% | +4.11% | Buy | ||
| 56 | -2.02% | +0.69% | -5.43% | -13.29% | 47.92x | 3.49x | +11.52% | +7.68% | +10.12% | +21.32% | Buy |
Healthcare Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.